Cancer Family
Solid Neoplasm
CI-CAN-00000052Explore in graph →
Non-malignant1,823 active trials28 evidence items
- NCIt
- C9292
Loading cancer entity…
Loading cancer entity…
Cancer Family
CI-CAN-00000052Explore in graph →
Clinical trials
6,089 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT00324597 | AMG 706 and Gemcitabine in Treating Patients With Advanced Solid Tumors or Lymphoma | unknown | Phase 1 | 18 | Jonsson Comprehensive Cancer CenterOTHER | 1 | Sep 17, 2013 | clinicaltrials |
| NCT00674947 | A Phase I Study of BIIB015 in Relapsed/Refractory Solid Tumors | completed | Phase 1 | 55 | BiogenINDUSTRY | 1 | Sep 16, 2013 | clinicaltrials |
| NCT01017198 |
| Effect of Food and Antacid on BIIB021 With Advanced Solid Tumors |
| completed |
| Phase 1 |
| 20 |
| BiogenINDUSTRY |
| 1 |
| Sep 16, 2013 |
| clinicaltrials |
| NCT00721669 | A Phase I Dose-Escalation Study of IMGN388 in Patients With Solid Tumors | completed | Phase 1 | 60 | ImmunoGen, Inc.INDUSTRY | 1 | Sep 13, 2013 | clinicaltrials |
| NCT00387504 | Fenretinide in Treating Patients With Metastatic or Unresectable Malignant Solid Tumors | completed | Phase 1 | 21 | California Cancer ConsortiumNETWORK | 1 | Sep 12, 2013 | clinicaltrials |
| NCT00002939 | Irinotecan and Paclitaxel in Treating Patients With Metastatic or Recurrent Cancer | completed | Phase 1 | 21 | University of ChicagoOTHER | 1 | Sep 5, 2013 | clinicaltrials |
| NCT00550199 | LBH589 and Gemcitabine in the Treatment of Solid Tumors | terminated | Phase 1 | 17 | SCRI Development Innovations, LLCOTHER | 1 | Aug 19, 2013 | clinicaltrials |
| NCT00793975 | Study of IMC-1121B in Patients With Tumors That Have Not Responded to Therapy | completed | Phase 1 | 37 | Eli Lilly and CompanyINDUSTRY | 1 | Aug 19, 2013 | clinicaltrials |
| NCT01212341 | Allogeneic Natural Killer (NK) Cell Therapy in Patients With Lymphoma or Solid Tumor(MG4101) | completed | Phase 1 | 18 | Seoul National University HospitalOTHER | 1 | Aug 19, 2013 | clinicaltrials |
| NCT00569036 | Multiple Dose Study In Cancer Patients: Safety and Tolerability of BMS-754807 in Advanced or Metastatic Solid Tumors | completed | Phase 1 | 63 | Bristol-Myers SquibbINDUSTRY | 1 | Aug 14, 2013 | clinicaltrials |
| NCT01437280 | GOAT; Phase I Open Label Study of CGTG-102, a GM-CSF Encoding Oncolytic Adenovirus, for Advanced Cancers(GOAT) | withdrawn | Phase 1 | 0 | Baylor College of MedicineOTHER | 0 | Aug 14, 2013 | clinicaltrials |
| NCT00020644 | Continuous Infusion Gemcitabine in Treating Patients With Advanced Metastatic Cancer | unknown | Phase 1 | — | Advocate Lutheran General HospitalOTHER | 1 | Aug 7, 2013 | clinicaltrials |
| NCT00017537 | Vaccine Therapy in Treating Patients With Metastatic or Recurrent Cancer | withdrawn | Phase 1 | 0 | University of Alabama at BirminghamOTHER | 0 | Aug 5, 2013 | clinicaltrials |
| NCT00248521 | 17-Dimethylaminoethylamino-17-Demethoxygeldanamycin (17-DMAG) in Treating Patients With Metastatic Solid Tumors or Tumors That Cannot Be Removed By Surgery | unknown | Phase 1 | 35 | Institute of Cancer Research, United KingdomOTHER | 1 | Aug 2, 2013 | clinicaltrials |
| NCT00749502 | A Study of MK4827 in Participants With Advanced Solid Tumors or Hematologic Malignancies (MK-4827-001 AM8) | completed | Phase 1 | 113 | Tesaro, Inc.INDUSTRY | 0 | Jul 25, 2013 | clinicaltrials |
| NCT00002543 | Gallium Nitrate in Treating Children With Brain Tumor, Neuroblastoma, Rhabdomyosarcoma, Non-Hodgkin's Lymphoma, or Refractory Solid Tumors | completed | Phase 1 | 3 | Medical College of WisconsinOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00003108 | Cisplatin Plus Bryostatin 1 in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Lombardi Comprehensive Cancer CenterOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00004213 | 3-Aminopyridine-2-carboxaldehyde Thiosemicarbazone in Treating Patients With Solid Tumors | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00004216 | VNP20009 in Treating Patients With Advanced or Metastatic Solid Tumors That Have Not Responded to Previous Therapy | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00006218 | 3-AP in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00006254 | VNP20009 in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00016874 | 3-AP Plus Cisplatin and Paclitaxel in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00024323 | Combination Chemotherapy in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00025129 | VNP40101M in Treating Patients With Advanced Solid Tumors or Lymphomas | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00049699 | VNP40101M in Treating Patients With Advanced or Metastatic Cancer | completed | Phase 1 | — | Vion PharmaceuticalsINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00112645 | Donor Stem Cell Transplant in Treating Young Patients With Relapsed or Refractory Solid Tumors | completed | Phase 1 | 10 | Milton S. Hershey Medical CenterOTHER | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00562380 | AMG-479 in Treating Patients With Advanced Solid Tumors or Non-Hodgkin Lymphoma | completed | Phase 1 | 64 | AmgenINDUSTRY | 1 | Jul 18, 2013 | clinicaltrials |
| NCT00869388 | A Phase I Study of Bi-Weekly rBBX-01 in Patients With Solid Tumors | completed | Phase 1 | 12 | Washington University School of MedicineOTHER | 1 | Jul 15, 2013 | clinicaltrials |
| NCT00005021 | Combination Chemotherapy With or Without Biological Therapy in Treating Patients With Refractory Solid Tumor or Lymphoma | completed | Phase 1 | 17 | Fox Chase Cancer CenterOTHER | 1 | Jul 11, 2013 | clinicaltrials |
| NCT00004090 | Gemcitabine and Cisplatin in Treating Patients With Metastatic or Recurrent Solid Tumors | completed | Phase 1 | — | Northwestern UniversityOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00045318 | Exatecan Mesylate in Treating Patients With Advanced Solid Tumors and Kidney Dysfunction | completed | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00072228 | Soblidotin and Gemcitabine in Treating Patients With Locally Advanced or Metastatic Solid Tumors | withdrawn | Phase 1 | — | Daiichi PharmaceuticalsINDUSTRY | 1 | Jul 10, 2013 | clinicaltrials |
| NCT00012194 | 7-hydroxystaurosporine and Cisplatin in Treating Patients With Advanced Malignant Solid Tumors | terminated | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jul 9, 2013 | clinicaltrials |
| NCT00003103 | Chemotherapy in Treating Patients With Solid Tumors | completed | Phase 1 / Phase 2 | 57 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jul 3, 2013 | clinicaltrials |
| NCT00004919 | Irinotecan and Cisplatin With or Without Amifostine in Treating Children With Solid Tumors That Have Not Responded to Previous Therapy | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00012181 | Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or Lymphomas | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00072436 | Gemcitabine Hydrochloride and Alvocidib in Treating Patients With Solid Tumors | completed | Phase 1 | 58 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00331955 | Vorinostat and Doxorubicin in Treating Patients With Metastatic or Locally Advanced Solid Tumors | completed | Phase 1 | 40 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00994500 | Vorinostat and Bortezomib in Treating Young Patients With Refractory or Recurrent Solid Tumors, Including Central Nervous System Tumors and Lymphoma | completed | Phase 1 | 20 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2013 | clinicaltrials |
| NCT00036777 | UCN-01 and Carboplatin in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | National Cancer Institute (NCI)NIH | 1 | Jul 1, 2013 | clinicaltrials |
| NCT00003198 | Ifosfamide and Topotecan in Treating Patients With Refractory Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 27, 2013 | clinicaltrials |
| NCT00003197 | Green Tea Extract in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | 30 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00003555 | Paclitaxel Plus Chemoprotection With Amifostine in Treating Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 20 | State University of New York - Upstate Medical UniversityOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00003969 | Geldanamycin Analogue in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Cancer Research UKOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00004881 | Vaccine Therapy in Treating Patients With Advanced Cancer | completed | Phase 1 | — | Jonsson Comprehensive Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00016861 | Irinotecan in Treating Children With Refractory or Progressive Solid Tumors | completed | Phase 1 | — | Texas Children's Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00024245 | 10-Propargyl-10-Deazaaminopterin Plus Probenecid in Treating Patients With Advanced Solid Tumors | completed | Phase 1 | — | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 26, 2013 | clinicaltrials |
| NCT00513981 | High-Dose Methotrexate in Treating Young Patients With Solid Tumors | completed | Phase 1 | 36 | Children's Cancer and Leukaemia GroupOTHER | 2 | Jun 26, 2013 | clinicaltrials |
| NCT00003359 | T138067 Sodium in Treating Patients With Advanced Refractory Cancer | completed | Phase 1 | 24 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
| NCT00003430 | L-778,123 in Treating Patients With Recurrent or Refractory Solid Tumors | completed | Phase 1 | 40 | Memorial Sloan Kettering Cancer CenterOTHER | 1 | Jun 25, 2013 | clinicaltrials |
Data updated 23 days agoSource updated Sep 17, 2013source: clinicaltrials